Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6583183 | 0.92 | NAMPT (0.74) | NAMPTTYMS | |
| SCHEMBL6585789 | 0.91 | NAMPT (0.73) | NAMPTTYMS | |
| SCHEMBL6584516 | 0.89 | NAMPT (0.76) | NAMPTTYMS | |
| SCHEMBL6580696 | 0.89 | NAMPT (0.90) | NAMPTTYMS | |
| SCHEMBL6582323 | 0.89 | NAMPT (0.91) | NAMPTTYMS | |
| SCHEMBL6582965 | 0.86 | NAMPT (0.52) | NAMPT | |
| SCHEMBL6583674 | 0.85 | NAMPT (0.93) | NAMPTTYMS | |
| SCHEMBL31181450 | 0.84 | NAMPT (1.00) | NAMPTTYMS | |
| SCHEMBL6584545 | 0.84 | NAMPT (1.00) | NAMPTTYMS | |
| SCHEMBL30205388 | 0.84 | NAMPT (1.00) | NAMPTTYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1155012-B1 | ANTI-CANCER DIHYDROQUINAZOLINE DERIVATIVES | CANCER REC TECH LTD (GB) | 2004-04-14 | — | — | EP | claimed |
| US-6699861-B1 | ANTI-CANCER | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2004-03-02 | — | — | US | claimed |
| JP-2002537391-A | — | — | 2002-11-05 | — | — | JP | claimed |
| EP-1155012-A1 | ANTI-CANCER DIHYDROQUINAZOLINE DERIVATIVES | Cancer Research Ventures Limited (GB) | 2001-11-21 | — | — | EP | claimed |
| WO-2000050417-A1 | ANTI-CANCER DIHYDROQUINAZOLINE DERIVATIVES | CANCER RESEARCH VENTURES LIMITED (GB) | 2000-08-31 | — | — | WO | claimed |
| EP-1155012-B1 | ANTI-CANCER DIHYDROQUINAZOLINE DERIVATIVES | CANCER REC TECH LTD (GB) | 2004-04-14 | — | — | EP | disclosed |
| US-6699861-B1 | ANTI-CANCER | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2004-03-02 | — | — | US | disclosed |
| EP-1155012-A1 | ANTI-CANCER DIHYDROQUINAZOLINE DERIVATIVES | Cancer Research Ventures Limited (GB) | 2001-11-21 | — | — | EP | disclosed |
| WO-2000050417-A1 | ANTI-CANCER DIHYDROQUINAZOLINE DERIVATIVES | CANCER RESEARCH VENTURES LIMITED (GB) | 2000-08-31 | — | — | WO | disclosed |